These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 340030)

  • 41. Classification according to chemical structure, mutagenicity to Salmonella and level of carcinogenicity of a further 42 chemicals tested for carcinogenicity by the U.S. National Toxicology Program.
    Ashby J; Tennant RW; Zeiger E; Stasiewicz S
    Mutat Res; 1989 Jun; 223(2):73-103. PubMed ID: 2662004
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Mutagens that are not carcinogens: faulty theory or faulty tests?
    Zeiger E
    Mutat Res; 2001 May; 492(1-2):29-38. PubMed ID: 11377241
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Response of the ke test to NCI/NTP-screened chemicals. I. Non-genotoxic carcinogens and genotoxic non-carcinogens.
    Bakale G; McCreary RD
    Carcinogenesis; 1990 Oct; 11(10):1811-8. PubMed ID: 2208594
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Determination of compound-specific acceptable daily intakes for 11 mutagenic carcinogens used in pharmaceutical synthesis.
    Ellis P; Kenyon M; Dobo K
    Regul Toxicol Pharmacol; 2013 Mar; 65(2):201-13. PubMed ID: 23228434
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The mutagenicity of 45 nitrosamines in the Salmonella typhimurium.
    Andrews AW; Lijinsky W
    Teratog Carcinog Mutagen; 1980; 1(3):295-303. PubMed ID: 6119819
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Mutagenicity of 42 chemicals in Salmonella.
    Zeiger E
    Environ Mol Mutagen; 1990; 16 Suppl 18():32-54. PubMed ID: 2091923
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Mutagenicity tests with a permeable mutant of yeast on carcinogens showing false-negative in Salmonella assay.
    Morita T; Iwamoto Y; Shimizu T; Masuzawa T; Yanagihara Y
    Chem Pharm Bull (Tokyo); 1989 Feb; 37(2):407-9. PubMed ID: 2663199
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Characterization and validation of an in silico toxicology model to predict the mutagenic potential of drug impurities.
    Valerio LG; Cross KP
    Toxicol Appl Pharmacol; 2012 May; 260(3):209-21. PubMed ID: 22426359
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Mutagenicity of chalks. A case in which the test results led to the improvement of the quality of commercial goods.
    Hayatsu H; Ohara Y; Hayatsu T; Togawa K
    Mutat Res; 1983 Oct; 124(1):1-7. PubMed ID: 6355835
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Mutagenic epoxide impurities discovered in two new beta-adrenergic blocking agents.
    Quinto I; Staiano N; Martire G; Friscia GO; Signorini M; de Lorenzo F
    Toxicol Lett; 1980 Feb; 5(2):109-14. PubMed ID: 6110255
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Stability of microsomal enzymes associated with the conversion of carcinogens to bacterial mutagens (Amens' Salmonella/microsome test) to freezing and thawing.
    Ashwood-Smith MJ
    Cryobiology; 1977 Apr; 14(2):240-4. PubMed ID: 324711
    [No Abstract]   [Full Text] [Related]  

  • 52. Mutagenic activity of Fusarium moniliforme isolates in the Salmonella typhimurium assay.
    Bjeldanes LF; Thomson SV
    Appl Environ Microbiol; 1979 Jun; 37(6):1118-21. PubMed ID: 384905
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Protacine. Absence of mutagenicity on Salmonella/mammalian microsome test.
    Vidal y Plana RR; Bizzarri D; Ferrari E
    Farmaco Prat; 1978 Dec; 33(12):543-6. PubMed ID: 374110
    [No Abstract]   [Full Text] [Related]  

  • 54. What is the role of histidine in studies of faecal mutagenicity?
    Silverman SH; Turnell DC; Youngs DJ; Keighley MR
    Mutat Res; 1986 Feb; 173(2):99-104. PubMed ID: 3511371
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Chemical purity and mutagenicity: case study of a drug in development.
    Kropko ML; Jaen JC; Theiss JC; Wold S; Caprathe BW; Wise LD
    Mutat Res; 1992 Apr; 281(4):233-8. PubMed ID: 1373215
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Mutagenic impurities in 1,3-dichloropropene preparations.
    Talcott RE; King J
    J Natl Cancer Inst; 1984 May; 72(5):1113-6. PubMed ID: 6585587
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Mutagenicity and carcinogenicity of mono- and diacetyl hydrazine.
    Bhide SV; Bhalerao EB; Sarode AV; Maru GB
    Cancer Lett; 1984 Jun; 23(2):235-40. PubMed ID: 6378363
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Miniaturization of the microsuspension Salmonella/microsome assay in agar microplates.
    Zwarg JRRM; Morales DA; Maselli BS; Brack W; Umbuzeiro GA
    Environ Mol Mutagen; 2018 Jul; 59(6):488-501. PubMed ID: 29668047
    [TBL] [Abstract][Full Text] [Related]  

  • 59. pH-sensitive mutagenic activity in ozone-treated 1,2-dimethylhydrazine in the Salmonella/microsome assay.
    Chambers TM; Burleson GR
    Mutat Res; 1982 May; 94(1):23-9. PubMed ID: 7048084
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Nitropyrenes: isolation, identificaton, and reduction of mutagenic impurities in carbon black and toners.
    Rosenkranz HS; McCoy EC; Sanders DR; Butler M; Kiriazides DK; Mermelstein R
    Science; 1980 Aug; 209(4460):1039-43. PubMed ID: 6996095
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.